4
Changes in Ownership
Iambic Therapeutics, Inc. Filed Acc 0002034921-26-000007
Chief Executive Officer acquired 132,200 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Miller Thomas F. Chief Executive Officer | 2026-10-14 | Grant or award | +132,200 | 1,410,756 | D | ||
| Derivatives | |||||||
| Miller Thomas F. Chief Executive Officer | 2026-10-14 | Grant or award · Employee Stock Option (right to buy) | +793,200 | 793,200 | D | ||
Loading xslF345X06/form4-10162026_081045.xml…